ImmunArray

ImmunArray is a clinically driven company specializing in molecular diagnostic tests designed to support the diagnosis and prognosis of complex medical conditions. The company primarily serves healthcare providers, including rheumatologists and neurologists, by offering innovative diagnostic solutions. Operating in the medical diagnostics market, ImmunArray focuses on developing assays and multiplex tests that enhance patient triage and treatment decisions. Their flagship product, 'Talk to Us,' is a diagnostic test that helps rule out Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease. Additionally, their BRAINBox program aims to improve the diagnosis and prognosis of brain injuries, including both acute traumatic brain injury (TBI) and chronic phases.

ImmunArray's business model revolves around the development and commercialization of these diagnostic tests, generating revenue through the sale of test kits and related services to healthcare institutions. The company collaborates with various partners and stakeholders in the healthcare sector to advance its research and product offerings.

Keywords: Molecular diagnostics, Systemic Lupus Erythematosus, SLE, brain injury, TBI, assays, multiplex tests, healthcare providers, patient triage, clinical rheumatology.